Hirsh, Andrew J. et al
"Pharmacological Properties of 552-02, a Novel Epithelial Sodium Channel Blocker with Potential Clinical Efficacy for Cystic Fibrosis Lung Disease." Journal of Pharmacology and Experimental Therapeutics
(2008):
.
Web. 18 April. 2024.